Pharmaceutical Quality (Industry)
1.0.0-ballot - ballot
Pharmaceutical Quality (Industry)
1.0.0-ballot - ballot
This page is part of the Pharmaceutical Quality (Industry) (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
| Active as of 2023-12-18 |
Generated Narrative: PlanDefinition
Resource PlanDefinition "plandefinition-drug-pq-ex3-drug-specification"
Profile: PlanDefinition - Drug PQ
StructureDefinition Work Group: brr
url: http://hl7.org/fhir/uv/pharm-quality/PlanDefinition/plandefinition-drug-pq-ex3-drug-specification
version: 1.0.0-ballot
title: SPECIFICATION(S) FOR DRUG PRODUCT
status: active
subject: MedicinalProductDefinition/medicinalproductdefinition-drug-product-pq-ex1
date: 2023-12-18 16:00:45+0000
publisher: HL7 International / Biomedical Research and Regulation
contact: HL7 International - Biomedical Research and Regulation: http://www.hl7.org/Special/committees/rcrim
description: Narrative description of specifications
jurisdiction: World (m49.htm#001)
action
title: Specification(s) for Drug Product
code: Overall set of actions ()
action
title: Release
code: Timing Group ()
timing: Code: Release time
action
action
action
action
action
action
action
action
action
title: End of shelf life
code: Timing Group ()
timing: Code: At end of shelf life
action
action
action
action
action
action
action
action
IG © HL7 International / Biomedical Research and Regulation. Package hl7.fhir.uv.pharm-quality#1.0.0-ballot based on FHIR 5.0.0. Generated 2023-12-18
Links: Table of Contents |
QA Report
| Version History |
|
Propose a change